Monashee Investment Management LLC
Source: SEC Form 13F · as of Mar 2026Monashee Investment Management LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $71.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$71.3M
| Company | Shares | Value |
|---|---|---|
| TERNTerns Pharmaceuticals, Inc. | 300,000 | $15.8M |
| SLDBSolid Biosciences Inc. | 1,420,295 | $10.2M |
| NKTRNEKTAR THERAPEUTICS | 100,000 | $7.2M |
| CYTKCYTOKINETICS INC | 100,000 | $6.6M |
| BBIOBridgeBio Pharma, Inc. | 67,139 | $5.0M |
| EVMNEvommune, Inc. | 179,340 | $4.1M |
| MANEVeradermics Incorporated | 50,000 | $3.2M |
| ZBIOZenas BioPharma, Inc. | 150,000 | $2.9M |
| KYMRKymera Therapeutics, Inc. | 35,100 | $2.9M |
| SGPSpyGlass Pharma Inc. | 95,000 | $2.5M |
| GPCRStructure Therapeutics Inc. | 50,000 | $2.4M |
| CRSPCRISPR Therapeutics AG | 50,000 | $2.4M |
| SABSSAB BIOTHERAPEUTICS, INC. | 500,000 | $1.9M |
| ACRSAclaris Therapeutics, Inc. | 500,000 | $1.9M |
| CMPXCompass Therapeutics, Inc. | 258,865 | $1.4M |
| VIRVir Biotechnology, Inc. | 100,000 | $896K |
| MSLESatellos Bioscience Inc. | 12,000 | $68K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.